Lung Cancer Chemoprevention: Isothiocyanates, inositol
Principal Investigator: Stephen Hecht
Abstract: Lung cancer is the most common cancer in the world. There are over 1 million cases of lung cancer annually, and the numbers are still increasing. Cigarette smoking causes 90% of lung cancer. In spite of progress in controlling cigarette smoking worldwide, there has been little change in smoking prevalence in the last decade. There are presently 1.1 billion smokers in the world. Ex-smokers are also at high risk for lung cancer. In 2000, there were 44.3 million ex-smokers in the U.S. Chemoprevention is a viable strategy to reduce lung cancer incidence and mortality. Our goal is to develop mixtures of chemopreventive agents which can inhibit lung cancer in smokers and ex-smokers. Based on consistent epidemiologic data that vegetable consumption protects against lung cancer, our overall hypothesis is that there are effective chemopreventive agents in vegetables. Together with our colleagues, we have developed naturally occurring isothiocyanates, their N-acetylcysteine conjugates, and myo-inositol (MI) as chemopreventive agents against lung cancer. Our studies demonstrate that these compounds, individually and in combination, are effective chemopreventive agents in a variety of animal models in which lung tumors are induced by the principal carcinogens in tobacco smoke. The goal of this proposal is to carry out translational research to further develop these agents for chemoprevention of lung cancer in smokers and ex-smokers. The specific aims are: 1. Develop methods to quantify DNA adducts of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in induced sputum or bronchial biopsies from smokers. Our studies clearly demonstrate that the major mechanism by which 2-phenylethyl isothiocyanate (PEITC) inhibits lung tumor induction by NNK in rats and mice is inhibition of DNA pyridyloxobutylation in the lung. Clinical trials of PEITC or its N-acetylcysteine conjugate (PEITC-NAC) in smokers must address this specific question, but the required methodology is not currently available. 2. Further evaluate the efficacy against lung tumorigenesis of a mixture of PEITC-NAC and MI. These studies will be carried out in A/J mice treated with the tobacco smoke carcinogens benzo[a]pyrene (BaP) plus NNK or exposed to tobacco smoke. 3. Using mass spectrometry-based proteomics methods, identify proteins with differing levels of expression in the lungs of mice treated with BaP plus NNK and chemopreventive agents in Specific Aim 2. These studies are intended to uncover new mechanistic leads and biomarkers relevant to lung carcinogenesis and chemoprevention. The results of this project will provide a solid foundation for clinical trials of isothiocyanates, their N-acetylcysteine conjugates, and MI as chemopreventive agents against lung cancer, by establishing efficacy without toxicity, by further elucidating mechanisms, and by identifying practical biomarkers.
Funding Period: 2004-05-10 - 2010-04-30
more information: NIH RePORT
- Cigarette smoking: cancer risks, carcinogens, and mechanismsStephen S Hecht
The Cancer Center, University of Minnesota, Box 806 Mayo, 420 Delaware Street SE, Minneapolis, MN, USA
Langenbecks Arch Surg 391:603-13. 2006..Cigarette smoking causes about 30% of all cancer mortality in developed countries. Although smoking is decreasing in developed countries, it is increasing in some developing countries...
- Indole-3-carbinol inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo(a)pyrene-induced lung tumorigenesis in A/J mice and modulates carcinogen-induced alterations in protein levelsFekadu Kassie
Cancer Center, University of Minnesota, Minneapolis, Minnesota 55455, USA
Cancer Res 67:6502-11. 2007....
- Combinations of N-Acetyl-S-(N-2-Phenethylthiocarbamoyl)-L-Cysteine and myo-inositol inhibit tobacco carcinogen-induced lung adenocarcinoma in miceFekadu Kassie
University of Minnesota Cancer Center, Mayo Mail Code 806, 420 Delaware Street Southeast, Minneapolis, MN 55455, USA
Cancer Prev Res (Phila) 1:285-97. 2008....
- Dose-dependent inhibition of tobacco smoke carcinogen-induced lung tumorigenesis in A/J mice by indole-3-carbinolFekadu Kassie
Masonic Cancer Center, University of Minnesota, 420 Delaware Street Southeast, Minneapolis, MN 55455, USA
Cancer Prev Res (Phila) 1:568-76. 2008....
- Chemopreventive agents modulate the protein expression profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumors in A/J miceFekadu Kassie
University of Minnesota Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, MN 55455, USA
Carcinogenesis 29:610-9. 2008..These proteins may have utility for development of candidate lung cancer biomarkers and as targets of chemopreventive/chemotherapeutic agents...
- Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokersStephen S Hecht
Masonic Cancer Center, University of Minnesota, Mayo Mail Code 806, 420 Delaware Street South East, Minneapolis, Minnesota 55455, USA
Nat Rev Cancer 9:476-88. 2009..It seems likely that logically constructed mixtures of these agents, developed from the ground up, will be necessary for the prevention of lung carcinogenesis...
- Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J miceFekadu Kassie
Masonic Cancer Center, Mayo Mail Code 806, Minneapolis, MN 55455, USA
Carcinogenesis 31:239-45. 2010..Our data show that I3C and MI inhibit lung carcinoma and provide a basis for future evaluation of these compounds in clinical trials as chemopreventive agents for current and former smokers...
- Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combinationFekadu Kassie
Masonic Cancer Center, University of Minnesota, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, MN 55455, USA
Carcinogenesis 31:1634-41. 2010..In conclusion, our studies demonstrated the promise of combinations of PEITC-NAC, I3C/DIM and MI for the chemoprevention of lung carcinogenesis in current and former smokers...